日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The European medicines agency review of belzutifan (Welireg) for the treatment of adult patients with von Hippel-Lindau disease-associated tumors

欧洲药品管理局对用于治疗成人von Hippel-Lindau病相关肿瘤的belzutifan(Welireg)的审查

Baron, Antonella; Broekman, Esther; van Gils, Martijn; Poplavska, Elita; Mol, Peter; Saliete, Ieva; Sepodes, Bruno; Pean, Elias